Innogen · News · February 7, 2014

Innogen Weekly News Roundup (25/01/14 - 07/02/14)

Innogen Weekly News Roundup (25/01/14 - 07/02/14)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.

Agriculture

Syngenta Chief Slams EU Pesticide Ban (Wall Street Journal)

GM crops containing fish oil nutrients could be grown in UK within months (Telegraph)

Forum Stresses Role of Women in Agricultural Value Chain (All Africa)

Mike Mack on GMOs: ‘There Is Very Little About Farming That’s Natural’ (Huffington Post)

Rothamsted Research seeks permission for GM field trials (Agriland)

Africa and India cultivate agricultural research ties (SciDevNet)

Ethiopia plan GM crop boost for cotton industry (Reuters AlertNet)

Resistance Over GMOs as South Africa Pushes Biotechnology (Inter Press Service)

FCC’s Agricultural Knowledge Exchange talks finance (Meridian Booster)

Monsanto plans research into conventional wheat, not genetically modified, in Montana (The Republic)

Monsanto Pitches Standards for Farm Data (Wall Street Journal)

Syngenta says ‘sold out’ of GMO corn trait banned by China (Reuters)

Germany to abstain in EU vote on new GMO maize (Reuters)

Bioeconomy

BioQuarter director reveals his hopes for Edinburgh firm as they make inroads to battle diseases and continue to grow (Daily Record)

Schäuble warns green policies are harming German economy (Financial Times)

Food & Energy Security

Scientists from developing countries collaborate for climate change research (Daily Times)

Is global food security jeopardized by an old age time bomb? (Guardian)

Genes & Genomics

Birth of the genetically modified HUMAN: Babies born with tweaked DNA could be in the UK next year (Daily Mail)

Global Development

Investors Flee Developing Countries (Wall Street Journal)

What an American World Looks Like, in Two Charts (National Review)

How Is Technology Driving Job Creation In Poor Countries? (Huffington Post)

Global Health

If The Immunity Project Crowdfunds This Synthetic AIDS Vaccine, They’ll Offer It Free to Everyone (Fast Company)

Gates and Summers Push Global Health Drive as Moral Imperative (New York Times)

GAVI raises $152 million for vaccinations with private sector partnerships (Vaccine News Daily)

Selcia and University of Edinburgh to fight Sleeping Sickness (Business Weekly)

Healthcare

Big data gets physical (Guardian)

Could the stem cell ‘repair kit’ become a reality? Diseases from cancer to Alzheimer’s could be cured using a single cell (Daily Mail)

Treatment lifeline for patients with rare illnesses (Herald Scotland)

Cells from eyes of dead ‘may give sight to blind’ (BBC)

Pharma

Report Assesses Social Media Engagement by Pharmaceutical Companies (Pharmacy Times)

‘Drug approvals in India drop 11-fold in 2013’ (Indian Express)

A third of new drug approvals are based on only one trial (Digital Journal)

Big Pharma Backs Big Data Summit In Cambridge (Business Weekly)

Pharma drug development only for wealthy countries? (Times of India)

Pharma cited in EU corruption report (PMLive)

Pharma firms join NIH on drug development (Nature)

Big Pharma pushes for U.S. action against India over patent worries (Reuters)

Loss of drug patents delivers more pain to AstraZeneca (Financial Times)

Science & Technology

Why big data will have a big impact on sustainability (Guardian)

UK science to benefit from long-term capital plan (Times Higher Education)

Extraordinary stem cell method tested in human tissue (New Scientist)

Synthetic Biology

UK establishes three new synthetic biology research centres (Phys.org)

Innogen Associates

Mariana Mazzucato: Start-up myths and obsessions (Economist)